J. Goldman & CO LP Celcuity Inc. Transaction History

J. Goldman & CO LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.1 - $20.78 $127,971 - $188,599	-9,076 Reduced 28.21%	23,095 $378,000
Q1 2024 May 15, 2024	SELL	$13.74 - $21.6 $1.09 Million - $1.71 Million	-79,074 Reduced 71.08%	32,171 $694,000
Q4 2023 Feb 14, 2024	SELL	$8.7 - $15.02 $324,118 - $559,570	-37,255 Reduced 25.09%	111,245 $1.62 Million
Q3 2023 Nov 14, 2023	BUY	$8.96 - $10.75 $120,960 - $145,125	13,500 Added 10.0%	148,500 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$9.39 - $12.18 $1.27 Million - $1.64 Million	135,000 New	135,000 $1.48 Million

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $187M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.